MX2020000816A - Tratamiento de lesiones no inflamatorias. - Google Patents
Tratamiento de lesiones no inflamatorias.Info
- Publication number
- MX2020000816A MX2020000816A MX2020000816A MX2020000816A MX2020000816A MX 2020000816 A MX2020000816 A MX 2020000816A MX 2020000816 A MX2020000816 A MX 2020000816A MX 2020000816 A MX2020000816 A MX 2020000816A MX 2020000816 A MX2020000816 A MX 2020000816A
- Authority
- MX
- Mexico
- Prior art keywords
- methyl
- inflammatory lesions
- mono
- naphthacene
- tetrahydroxy
- Prior art date
Links
- 230000002757 inflammatory effect Effects 0.000 title abstract 2
- 230000003902 lesion Effects 0.000 title abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
- PQJQFLNBMSCUSH-SBAJWEJLSA-N chembl2364632 Chemical compound O=C1C2=C(O)[C@@](C(C(C(N)=O)=C(O)[C@H]3N(C)C)=O)(O)[C@H]3C[C@@H]2CC2=C1C(O)=CC=C2CN(C)OC PQJQFLNBMSCUSH-SBAJWEJLSA-N 0.000 abstract 1
- -1 methoxy(methyl)amino Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762535572P | 2017-07-21 | 2017-07-21 | |
| PCT/IB2018/000938 WO2019016609A1 (en) | 2017-07-21 | 2018-07-20 | TREATMENT OF NON-INFLAMMATORY LESIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020000816A true MX2020000816A (es) | 2020-08-17 |
Family
ID=63713912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020000816A MX2020000816A (es) | 2017-07-21 | 2018-07-20 | Tratamiento de lesiones no inflamatorias. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200222432A1 (https=) |
| EP (1) | EP3654988B1 (https=) |
| JP (1) | JP2020527607A (https=) |
| KR (1) | KR102662461B1 (https=) |
| CN (1) | CN111343991A (https=) |
| AU (1) | AU2018303807B2 (https=) |
| BR (1) | BR112020000968A2 (https=) |
| CA (1) | CA3070663A1 (https=) |
| ES (1) | ES2962380T3 (https=) |
| IL (1) | IL272124A (https=) |
| MA (1) | MA49641A (https=) |
| MX (1) | MX2020000816A (https=) |
| WO (1) | WO2019016609A1 (https=) |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990331A (en) | 1956-11-23 | 1961-06-27 | Pfizer & Co C | Stable solutions of salts of tetracyclines for parenteral administration |
| US2980584A (en) | 1957-10-29 | 1961-04-18 | Pfizer & Co C | Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation |
| US3062717A (en) | 1958-12-11 | 1962-11-06 | Pfizer & Co C | Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation |
| US3165531A (en) | 1962-03-08 | 1965-01-12 | Pfizer & Co C | 13-substituted-6-deoxytetracyclines and process utilizing the same |
| US3454697A (en) | 1965-06-08 | 1969-07-08 | American Cyanamid Co | Tetracycline antibiotic compositions for oral use |
| NL6607516A (https=) | 1966-05-31 | 1967-12-01 | ||
| DE1767891C3 (de) | 1968-06-28 | 1980-10-30 | Pfizer | Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat |
| US3957980A (en) | 1972-10-26 | 1976-05-18 | Pfizer Inc. | Doxycycline parenteral compositions |
| DE2442829A1 (de) | 1974-09-06 | 1976-03-18 | Merck Patent Gmbh | Tetracyclische verbindungen und verfahren zu ihrer herstellung |
| US4018889A (en) | 1976-01-02 | 1977-04-19 | Pfizer Inc. | Oxytetracycline compositions |
| US4126680A (en) | 1977-04-27 | 1978-11-21 | Pfizer Inc. | Tetracycline antibiotic compositions |
| EP1383508B1 (en) * | 2001-04-05 | 2006-06-21 | Collagenex Pharmaceuticals, Inc. | Doxycycline for the treatment of acne |
| US7704959B2 (en) * | 2006-10-03 | 2010-04-27 | Dow Pharmaceutical Sciences | Azithromycin for the treatment of nodular acne |
| CA2892739A1 (en) * | 2006-12-21 | 2008-07-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| WO2008079339A2 (en) | 2006-12-21 | 2008-07-03 | Paratek Pharmaceuticals, Inc. | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections |
| CA2724412A1 (en) * | 2008-05-21 | 2009-11-26 | Galderma Research & Development | Maintenance therapy regimen for treating acne |
| CN102056481A (zh) * | 2008-06-05 | 2011-05-11 | 陶氏制药科学公司 | 包含低浓度的在水和水混溶性有机溶剂中的悬浮液形式的过氧苯甲酰的局部药物制剂 |
| JP2013500984A (ja) * | 2009-07-30 | 2013-01-10 | アラーガン、インコーポレイテッド | ダプソンとアダパレンの組み合わせ |
| US20140121188A1 (en) * | 2009-10-02 | 2014-05-01 | Foamix Ltd. | Compositions for the improved treatment of acne and related disorders |
| US9255068B2 (en) * | 2011-05-12 | 2016-02-09 | Warner Chilcott Company, Llc | Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same |
| IL225246A0 (en) * | 2012-03-15 | 2013-06-27 | Meir Eini | Methods for speeding up the restoration of skin normality and for treatment of impetigo |
| GB201615693D0 (en) * | 2016-09-15 | 2016-11-02 | Combinatorx Infection Ltd | Combinations |
-
2018
- 2018-07-20 CN CN201880048978.1A patent/CN111343991A/zh active Pending
- 2018-07-20 EP EP18779747.7A patent/EP3654988B1/en active Active
- 2018-07-20 BR BR112020000968-7A patent/BR112020000968A2/pt not_active Application Discontinuation
- 2018-07-20 KR KR1020207003934A patent/KR102662461B1/ko active Active
- 2018-07-20 CA CA3070663A patent/CA3070663A1/en active Pending
- 2018-07-20 MX MX2020000816A patent/MX2020000816A/es unknown
- 2018-07-20 JP JP2020524697A patent/JP2020527607A/ja active Pending
- 2018-07-20 US US16/632,121 patent/US20200222432A1/en not_active Abandoned
- 2018-07-20 AU AU2018303807A patent/AU2018303807B2/en active Active
- 2018-07-20 WO PCT/IB2018/000938 patent/WO2019016609A1/en not_active Ceased
- 2018-07-20 MA MA049641A patent/MA49641A/fr unknown
- 2018-07-20 ES ES18779747T patent/ES2962380T3/es active Active
-
2020
- 2020-01-19 IL IL272124A patent/IL272124A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018303807B2 (en) | 2023-08-24 |
| CA3070663A1 (en) | 2019-01-24 |
| IL272124A (en) | 2020-03-31 |
| WO2019016609A1 (en) | 2019-01-24 |
| KR20200031126A (ko) | 2020-03-23 |
| EP3654988A1 (en) | 2020-05-27 |
| BR112020000968A2 (pt) | 2020-07-14 |
| ES2962380T3 (es) | 2024-03-18 |
| CN111343991A (zh) | 2020-06-26 |
| AU2018303807A1 (en) | 2020-02-13 |
| MA49641A (fr) | 2021-06-02 |
| US20200222432A1 (en) | 2020-07-16 |
| JP2020527607A (ja) | 2020-09-10 |
| KR102662461B1 (ko) | 2024-04-30 |
| EP3654988B1 (en) | 2023-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4424328A3 (en) | Treatment of hidradenitis suppurativa using jak inhibitors | |
| EA201590166A1 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| CA2588296A1 (en) | Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease | |
| US10085959B2 (en) | Compositions and methods for treating intestinal hyperpermeability | |
| RU2014111069A (ru) | Лекарственные формы ингибитора гистондиацетилазы в комбинации с бендамутином и их применение | |
| MA35090B1 (fr) | Polythérapie pour les malignités hématologiques | |
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| IL273169B1 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild) | |
| AU2014340303A1 (en) | Tyrosine hydroxylase inhibitors for treating intestinal hyperpermeability | |
| FI3493812T3 (fi) | Imetelstaatin ja venetoklaksin yhdistelmiä akuutin myelooisen leukemian hoitoa varten | |
| RU2013108258A (ru) | Применение разагилина для лечения обонятельной дисфункции | |
| FI3840753T3 (fi) | Migalastaatti käytettäväksi fabryn taudin hoitomenetelmissä potilailla joilla on gla-geenin mutaatio | |
| AR090885A1 (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple | |
| RU2018110580A (ru) | Проникающее в мозг производное оксима хромона для терапии леводопа-индуцированной дискинезии | |
| RU2011108486A (ru) | ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ПЕПТИДА Wnt5-a ДЛЯ ЛЕЧЕНИЯ МЕЛАНОМЫ И РАКА ЖЕЛУДКА | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| DOP2005000039A (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| MX2022003845A (es) | Tratamientos cognitivos medicinales. | |
| MX2020000816A (es) | Tratamiento de lesiones no inflamatorias. | |
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| CL2021003303A1 (es) | Tratamiento para sinucleinopatías. | |
| RU2020108631A (ru) | Новая вспомогательная терапия для применения в способе лечения рака простаты | |
| MX2022012693A (es) | Composicion que comprende metilfolato. | |
| RU2013149635A (ru) | Соединения солифенацина и слюнные стимулянты для лечения гиперактивности мочевого пузыря | |
| UY38340A (es) | Combinación farmacéutica sinérgica que comprende tramadol clorhidrato y pregabalina, y su uso para el tratamiento del dolor neuropático |